Evidence map›Paper›PMID 30939981›Full record

ArticlemAbs

From Rhesus macaque to human: structural evolutionary pathways for immunoglobulin G subclasses.

William David Tolbert, Ganesh Prasad Subedi, Neelakshi Gohain, George Kenneth Lewis, Kashyap Rajesh Patel, Adam Wesley Barb, Marzena Pazgier

Abstract readComparative Study
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Nonhuman primate models of pediatric viral diseases.Frontiers in cellular and infection microbiology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. IMGTVaccines · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

William David Tolberta Division of Vaccine Research , Institute of Human Virology of University of Maryland School of Medicine , Baltimore , MD , USA.ORCID 0000-0001-7549-9596
Ganesh Prasad Subedic Roy J. Carver Department of Biochemistry , Biophysics and Molecular Biology of Iowa State University , Ames , IA , USA.
Neelakshi Gohaina Division of Vaccine Research , Institute of Human Virology of University of Maryland School of Medicine , Baltimore , MD , USA.ORCID 0000-0003-1370-312X
George Kenneth Lewisa Division of Vaccine Research , Institute of Human Virology of University of Maryland School of Medicine , Baltimore , MD , USA.ORCID 0000-0003-4815-2604
Kashyap Rajesh Patelc Roy J. Carver Department of Biochemistry , Biophysics and Molecular Biology of Iowa State University , Ames , IA , USA.ORCID 0000-0001-8039-3972
Adam Wesley Barbc Roy J. Carver Department of Biochemistry , Biophysics and Molecular Biology of Iowa State University , Ames , IA , USA.
Marzena Pazgiera Division of Vaccine Research , Institute of Human Virology of University of Maryland School of Medicine , Baltimore , MD , USA.ORCID 0000-0003-0594-5057
University of Maryland, Baltimore · USIowa State University · US

Funding

Physical Resources CoreP01AI120756 · NIAID · DUKE UNIVERSITY · PI TOMARAS, GEORGIA DORIS · 2016 to 2020
$17.1M
Project 3- Mucosal Determinants of Virus TransmissionP01AI124912 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI GALLO, ROBERT C · 2016 to 2019
$14.4M
A new strategy to eliminate HIV-1-infected cells by unlocking the Env trimerR01AI174908 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI Marzena Elzbieta Pazgier · 2023 to 2026
$2.8M
Unlocking Envelope: A New Strategy for a Functional Cure Through Antibody-Dependent Cell-Mediated CytotoxicityR01AI129769 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PAZGIER, MARZENA ELZBIETA · 2017 to 2021
$2.3M
Structural Targeting of Potentially Protective gp120 Epitopes in the C1/C2 RegionR01AI116274 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PAZGIER, MARZENA ELZBIETA · 2016 to 2019
$1.5M
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactionsR01GM115489 · NIGMS · UNIVERSITY OF GEORGIA · PI BARB, ADAM WESLEY · 2015 to 2019
$1.4M
NIAID NIH HHS P01 AI120756NIAID NIH HHS P01 AI124912NIAID NIH HHS R01 AI116274NIAID NIH HHS R01 AI129769NIAID NIH HHS R01 AI174908NIGMS NIH HHS R01 GM115489
6 · The paper itself

Abstract

The Old World monkey, Rhesus macaque (Macaca mulatta, Mm), is frequently used as a primate model organism in the study of human disease and to test new vaccines/antibody treatments despite diverging before chimpanzees and orangutans. Mm and humans share 93% genome identity with substantial differences in the genes of the adaptive immune system that lead to different functional IgG subclass characteristics, Fcγ receptors expressed on innate immune cells, and biological interactions. These differences put limitations on Mm use as a primary animal model in the study of human disease and to test new vaccines/antibody treatments. Here, we comprehensively analyzed molecular properties of the Fc domain of the four IgG subclasses of Rhesus macaque to describe potential mechanisms for their interactions with effector cell Fc receptors. Our studies revealed less diversity in the overall structure among the Mm IgG Fc, with MmIgG1 Fc being the most structurally like human IgG3, although its C

Indexed as

AnimalsBiological EvolutionCrystallizationCrystallography, X-RayHumansImmunoglobulin Fc FragmentsImmunoglobulin IsotypesMacaca fascicularisMacaca mulattaProtein BindingProtein ConformationReceptors, IgGStructure-Activity RelationshipImmunoglobulin Fc FragmentsImmunoglobulin IsotypesReceptors, IgGcrystallizable fragmentFcIgG subclassesMacaca mulattaRhesus macaque

Identifiers

PMID30939981
PMCPMC6601566
OpenAlexW2931641461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.